Skip to main content
Top
Published in: Breast Cancer Research 1/2013

01-11-2013 | Poster presentation

PB.17: Inter-observer agreement in visual analogue scale assessment of percentage breast density

Authors: JC Sergeant, M Wilson, N Barr, U Beetles, C Boggis, S Bundred, M Bydder, S Gadde, E Hurley, A Jain, Y Lim, L Lord, V Reece, DG Evans, A Howell, SM Astley

Published in: Breast Cancer Research | Special Issue 1/2013

Login to get access

Excerpt

Breast density is an important risk factor for breast cancer. Assessment of density at screening could help identify women at increased risk of cancer, who may benefit from screening with shorter intervals or different modalities. Visual analogue scale (VAS) assessment of percentage density by observers is straightforward to implement and strongly associated with cancer risk. However, using VAS assessment for stratification would require reproducibility between observers. We examine agreement between observers assessing VAS density. …
Metadata
Title
PB.17: Inter-observer agreement in visual analogue scale assessment of percentage breast density
Authors
JC Sergeant
M Wilson
N Barr
U Beetles
C Boggis
S Bundred
M Bydder
S Gadde
E Hurley
A Jain
Y Lim
L Lord
V Reece
DG Evans
A Howell
SM Astley
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2013
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3517

Other articles of this Special Issue 1/2013

Breast Cancer Research 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine